p53 mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 11, 2001, Pages 675-680

  Khan, Z ^a   Jonas, S ^a   Feldmann, K ^a   Patel, H ^a   Wharton, R ^a   Tarragona, A ^b   Ivison, A ^b   Allen Mersh, T ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy response; Colorectal cancer; Hepatic arterial floxuridine; p53 mutation

Indexed keywords

FLOXURIDINE; FLUOROURACIL; PROTEIN P53; PYRIMIDINE; ZINC;

ADULT; ARTICLE; BINDING SITE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CANNULATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG CONTRAINDICATION; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER METASTASIS; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 0034799127     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320100248     Document Type: Article

References (35)

1. Apoptosis. Its significance in cancer and cancer therapy
2. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: Evidence for the involvement of RNA perturbation
3. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
4. Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity
5. p53 status and the efficacy of cancer therapy in vivo
6. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
7. p53 and behaviour of colorectal cancer
8. p53 and thymidylate synthase expression in untreated stage II colon cancer: Associations with recurrence, survival, and site
9. p53 and K-ras gene mutations correlate with tumour aggressiveness but are not of routine prognostic value in colorectal cancer
10. Lack of correlation between p53 overexpression and response to FUra-based chemotherapy in advanced colorectal cancer patients
11. p53 nuclear protein overexpression in colorectal cancer: A dominant predictor of survival in patients with advanced hepatic metastases
12. Relationship between p53 gene mutations and multidrug resistance (mdrl) gene expression in myelodysplastic syndromes
13. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation
14. p53 mutations in human cancers
15. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
16. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas
17. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival
18. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
19. Measurement of response to treatment in colorectal liver metastases
20. Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland
21. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer
22. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
23. One-tube post-PCR fluorescent labeling of DNA fragments
24. p53: At the crossroads of molecular arcinogenesis and risk assessment
25. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression
26. p53 mutations in primary colorectal adenocarcinomas and liver metastases
27. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53 independent induction of p21WAF1/CIP1 via C/EBPbeta
28. Disruption of p53 in human cancer cells alters the responses to therapeutic agents
29. p53 point mutation and survival in colorectal cancer patients
30. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines
31. Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription
32. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumours
33. Quantitation of intratumoural thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin
34. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine
35. Inhibition of telomerase limits the growth of human cancer cells